반응식
Cl.[CH3:2][C:3]1[CH:4]=[C:5]([CH:9]=[CH:10][N:11]=1)[C:6]([OH:8])=O.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[CH3:36][O:37][C:38]1[C:43]2[N:44]=[C:45]([NH2:47])[S:46][C:42]=2[C:41]([N:48]([CH2:50][CH2:51][O:52][CH3:53])[CH3:49])=[CH:40][CH:39]=1>C1COCC1.O1CCOCC1.CN(C=O)C>[CH3:36][O:37][C:38]1[C:43]2[N:44]=[C:45]([NH:47][C:6](=[O:8])[C:5]3[CH:9]=[CH:10][N:11]=[C:3]([CH3:2])[CH:4]=3)[S:46][C:42]=2[C:41]([N:48]([CH2:50][CH2:51][O:52][CH3:53])[CH3:49])=[CH:40][CH:39]=1참가 물질
7
반응물 3
생성물 1
시약·촉매·용매 3
실험 절차
From 2-methyl-isonicotinic acid hydrochloride, HATU and N-diethylisopropylamine in THF, then treatment with 4-methoxy-N7-(2-methoxy-ethyl)-N7-methyl-benzothiazole-2,7-diamine in dioxane and DMF. ES-MS m/e (%): 387 (M+H+, 100).
출처 및 근거
- ORD 기록
- ord-e7ff8e30833145d7a201030d65ddec20
- 출처 데이터셋
- uspto-grants-2004_03
- 특허 번호
- US06713499B2
연결된 노트
불러오는 중…